Literature DB >> 10868932

Hypothalamic localization of the feeding effect of agouti-related peptide and alpha-melanocyte-stimulating hormone.

M S Kim1, M Rossi, S Abusnana, D Sunter, D G Morgan, C J Small, C M Edwards, M M Heath, S A Stanley, L J Seal, J R Bhatti, D M Smith, M A Ghatei, S R Bloom.   

Abstract

The melanocortin-4 receptor (MC4R) in the hypothalamus is thought to be important in physiological regulation of food intake. We investigated which hypothalamic areas known to express MC4R are involved in the regulation of feeding by using alpha-melanocyte-stimulating hormone (alpha-MSH), an endogenous MC4R agonist, and agouti-related peptide (Agrp), an endogenous MC4R antagonist. Cannulae were inserted into the rat hypothalamic paraventricular (PVN), arcuate (Arc), dorsomedial (DMN), and ventromedial (VMN) nuclei; the medial preoptic (MPO), anterior hypothalamic (AHA), and lateral hypothalamic (LHA) areas; and the extrahypothalamic central nucleus of the amygdala (CeA). Agrp (83-132) (0.1 nmol) and [Nle4, D-Phe7]alpha(-MSH (NDP-MSH) (0.1 nmol), a stable alpha-MSH analog, were administered to fed and fasted rats, respectively. The PVN, DMN, and MPO were the areas with the greatest response to Agrp and NDP-MSH. At 8 h postinjection, Agrp increased feeding in the PVN by 218 +/- 23% (P < 0.005), in the DMN by 268 +/- 42% (P < 0.005), and in the MPO by 236 +/- 31% (P < 0.01) compared with a saline control group for each nucleus. NDP-MSH decreased food intake in the PVN by 52 +/- 6% (P < 0.005), in the DMN by 44 +/- 6% (P < 0.0001), and in the MPO by 55 +/- 6% (P < 0.0001) at 1 h postinjection. Injection into the AHA and CeA resulted in smaller alterations in food intake. No changes in feeding were seen after the administration of Agrp into the Arc, LHA, or VMN, but NDP-MSH suppressed food intake in the Arc and LHA. This study indicates that the hypothalamic nuclei expressing MC4R vary in their sensitivity to Agrp and alpha-MSH with regard to their effect on feeding.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10868932     DOI: 10.2337/diabetes.49.2.177

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  51 in total

1.  Influence of a novel inhibitor (UM8190) of prolylcarboxypeptidase (PRCP) on appetite and thrombosis.

Authors:  F M Rabey; R S V S Gadepalli; S Diano; Q Cheng; T Tabrizian; D Gailani; J M Rimoldi; Z Shariat-Madar
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

2.  Ghrelin regulates hypothalamic prolyl carboxypeptidase expression in mice.

Authors:  Jin Kwon Jeong; Jung Dae Kim; Sabrina Diano
Journal:  Mol Metab       Date:  2013-01-11       Impact factor: 7.422

3.  Changes in melanocortin expression and inflammatory pathways in fetal offspring of nonhuman primates fed a high-fat diet.

Authors:  B E Grayson; P R Levasseur; S M Williams; M S Smith; D L Marks; K L Grove
Journal:  Endocrinology       Date:  2010-02-22       Impact factor: 4.736

4.  The melanocortinergic pathway is rapidly recruited by emotional stress and contributes to stress-induced anorexia and anxiety-like behavior.

Authors:  Jing Liu; Jacob C Garza; Ha V Truong; John Henschel; Wei Zhang; Xin-Yun Lu
Journal:  Endocrinology       Date:  2007-08-02       Impact factor: 4.736

5.  Dorsomedial hypothalamus mediates autonomic, neuroendocrine, and locomotor responses evoked from the medial preoptic area.

Authors:  Joseph L Hunt; Dmitry V Zaretsky; Sumit Sarkar; Joseph A Dimicco
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-11-18       Impact factor: 3.619

6.  Prenatal programming by testosterone of hypothalamic metabolic control neurones in the ewe.

Authors:  K M Sheppard; V Padmanabhan; L M Coolen; M N Lehman
Journal:  J Neuroendocrinol       Date:  2011-05       Impact factor: 3.627

7.  Hypothalamic Sirt1 regulates food intake in a rodent model system.

Authors:  Işin Cakir; Mario Perello; Omar Lansari; Norma J Messier; Charles A Vaslet; Eduardo A Nillni
Journal:  PLoS One       Date:  2009-12-15       Impact factor: 3.240

8.  An animal model manifesting neurodegeneration and obesity.

Authors:  Etsuo Susaki; Keiichi I Nakayama
Journal:  Aging (Albany NY)       Date:  2010-07       Impact factor: 5.682

9.  Coordinated changes in energy intake and expenditure following hypothalamic administration of neuropeptides involved in energy balance.

Authors:  N M Semjonous; K L Smith; J R C Parkinson; D J L Gunner; Y-L Liu; K G Murphy; M A Ghatei; S R Bloom; C J Small
Journal:  Int J Obes (Lond)       Date:  2009-06-02       Impact factor: 5.095

10.  Prokineticin 2 is a hypothalamic neuropeptide that potently inhibits food intake.

Authors:  James V Gardiner; Attia Bataveljic; Neekhil A Patel; Gavin A Bewick; Debabrata Roy; Daniel Campbell; Hannah C Greenwood; Kevin G Murphy; Saira Hameed; Preeti H Jethwa; Francis J P Ebling; Steven P Vickers; Sharon Cheetham; Mohammad A Ghatei; Stephen R Bloom; Waljit S Dhillo
Journal:  Diabetes       Date:  2009-11-23       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.